OTDOncology Treatment Discovery3083-49962981-8079Bio-Byword Scientific Publishing Pty. Ltd.10.26689/otd.v2i1.6563ArticleAnalysis of a Case of Airway Hemangioma in a 1-Month-Old Infant with Dyspnea – A Secondary Publicationhttps://artdesignp.com/journal/OTD/2/1/10.26689/otd.v2i1.6563KimHyo-Bin,HongSang-Hwa,ChoiHee-Won,JungJin-A2024212024-03-29Infantile hemangiomas are the most common benign tumors of infancy. However, hemangiomas located in the respiratory tract are rare and could cause life-threatening events due to airway obstruction. To date, the best recommended treatment for infantile hemangioma is oral propranolol as it exhibits faster effects with fewer adverse effects as compared to systemic corticosteroid therapy. In this study, we reported a case of a 1-month-old girl who was presented with respiratory symptoms and hemangioma on the scalp. The hemangioma extended from the right base of the skull to the thoracic inlet, causing inspiratory stridor and dyspnea. Treatment with oral propranolol was initiated and her symptoms regressed. Imaging showed regression of the hemangioma. This was a rare case of skin hemangioma found on the scalp, in which the hemangioma extended from the base of the skull to the subglottis, precipitating respiratory symptoms from airway obstruction. Based on this encounter, the presentation of skin hemangioma on the head, coupled with respiratory symptoms, necessitates the use of imaging studies, such as computed tomography, ultrasound, and magnetic resonance imaging to ascertain the extent of hemangioma.

Haggstrom AN, Drolet BA, Baselga E, et al., 2007, Prospective Study of Infantile Hemangiomas: Demographic, Prenatal, and Perinatal Characteristics. J Pediatr, 150: 291–294.

Haggstrom AN, Lammer EJ, Schneider RA, et al., 2006, Patterns of Infantile Hemangiomas: New Clues to Hemangioma Pathogenesis and Embryonic Facial Development. Pediatrics, 117: 698–703.

Phipps CD, Gibson WS, Wood WE, 1997, Infantile Subglottic Hemangioma: A Review and Presentation of Two Cases of Surgical Excision. Int J Pediatr Otorhinolaryngol, 41: 71–79.

Wu L, Wu X, Xu X, et al., 2015, Propranolol Treatment of Subglottic Hemangiomas: A Review of The Literature. Int J Clin Exp Med, 8: 19886–19890.

Bauman NM, McCarter RJ, Guzzetta PC, et al., 2014, Propranolol vs Prednisolone for Symptomatic Proliferating Infantile Hemangiomas: A Randomized Clinical Trial. JAMA Otolaryngol Head Neck Surg, 140: 323–30.

Chang LC, Haggstrom AN, Drolet BA, et al., 2008, Growth Characteristics of Infantile Hemangiomas: Implications for Management. Pediatrics, 122: 360–367.

Tan S, Itinteang T, Leadbitter P, 2011, Low-Dose Propranolol for Infantile Haemangioma. J Plast Reconstr Aesthet Surg, 64: 292–299.

Greene AK, 2008, Corticosteroid Treatment for Problematic Infantile Hemangioma: Evidence Does Not Support an Increased Risk for Cerebral Palsy. Pediatrics, 121: 1251–1252.

Ezekowitz RA, Mulliken JB, Folkman J, 1992, Interferon Alfa-2a Therapy for Life-Threatening Hemangiomas of Infancy. N Engl J Med, 326: 1456–1463.

Storch CH, Hoeger PH, 2010, Propranolol for Infantile Haemangiomas: Insights into The Molecular Mechanisms of Action. Br J Dermatol, 163: 269–274.

Balma-Mena A, Chakkittakandiyil A, Weinstein M, et al., 2012, Propranolol in the Management of Infantile Hemangiomas: Clinical Response and Predictors. J Cutan Med Surg, 16: 169–173.

Kim KH, Choi TH, Choi Y, et al., 2017, Comparison of Efficacy and Safety Between Propranolol and Steroid for Infantile Hemangioma: A Randomized Clinical Trial. JAMA Dermatol, 153: 529–536.

Michaud AP, Bauman NM, Burke DK, et al., 2004, Spastic Diplegia and Other Motor Disturbances in Infants Receiving Interferon-alpha. Laryngoscope, 114: 1231–1236.

George ME, Sharma V, Jacobson J, et al., 2004, Adverse Effects of Systemic Glucocorticosteroid Therapy in Infants with Hemangiomas. Arch Dermatol, 140: 963–969.

Wörle H, Maass E, Köhler B, et al., 1999, Interferon Alpha-2a Therapy in Hemangiomas of Infancy: Spastic Diplegia as A Severe Complication. Eur J Pediatr, 158: 344.

Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, et al., 2008, Propranolol for Severe Hemangiomas of Infancy. N Engl J Med, 358: 2649–2651.

Léauté-Labrèze C, Hoeger P, Mazereeuw-Hautier J, et al., 2015, A Randomized, Controlled Trial of Oral Propranolol in Infantile Hemangioma. N Engl J Med, 372: 735–746.

McCormick AA, Tarchichi T, Azbell C, et al., 2018, Subglottic Hemangioma: Understanding the Association with Facial Segmental Hemangioma in a Beard Distribution. Int J Pediatr Otorhinolaryngol, 113: 34–37.